Control of pain with endogenous cannabinoids
AssigneesNeurosciences Research Foundation, Inc., Universita di Napoli Federico II
InventorsAntonio Calignano, Giovanna La Rana, Andrea Guiffrida, Daniele Piomelli
Life of this patent
Estimating the term…
Abstract
Novel pharmaceutical therapeutic compositions and methods for using same for the treatment of pain experienced by an individual are provided. The compositions contain at least one member selected from among anandamide and palmitylethanolamide
Claims15
A method for treating pain experienced by a mammal in need of such treatment, the method comprising:
- administering to the mammal a therapeutically effective amount of a pharmaceutical composition comprising at least one endogenous cannabinoid selected from the group consisting or anandamide and palmitylethanolamide, wherein said pharmaceutical composition is capable of inhibiting pain initiation.
A method for controlling pain transmission by administering a therapeutically effective level of a composition comprising anandamide and palmitylethanolamide.
A pharmaceutical composition comprising anandamide and palmitylethanolamide.
A pharmaceutical composition comprising anandamide, palmitylethanolamide and a pharmaceutically acceptable carrier for controlling pain transmission.
A pharmaceutical composition for controlling pain transmission comprising a therapeutically effective amount of anandamide, palmitylethanolaride and a pharmaceutically acceptable carrier sufficient to interact with CB1 and CB2 receptors.
A method for activating CB1- and CB2-like cannabinoid receptors by administering a therapeutically effective amount of a composition wherein said composition comprising anandamide and palmitylethanolamide.
Dependencies are inferred from the claim text.